Novel antiplatelet targets in the treatment of acute coronary syndromes.

Platelets
Fawaz O Alenazy, Mark R Thomas

Abstract

Acute coronary syndromes (ACS) are a global cause of mortality and morbidity that affect millions of lives worldwide. Following atherosclerotic plaque rupture, platelet activation and aggregation are the two major elements that initiate thrombus formation inside a coronary artery, which can obstruct blood flow and cause myocardial ischemia; ergo, antiplatelet therapy forms a major part of the treatment strategy for ACS. Patients with ACS routinely receive dual antiplatelet therapy (DAPT), which consists of aspirin and a platelet P2Y12 inhibitor to both treat and prevent atherothrombosis. Use of platelet glycoprotein (GP) IIb/IIIa inhibitors is now limited due to the risk of severe bleeding and thrombocytopenia. Thus, administration of GPIIb/IIIa inhibitors is generally restricted to bail out thrombotic events associated with PCI. Furthermore, current antiplatelet medications mainly rely on thromboxane A2 and P2Y12 inhibition, which have broad-acting effects on platelets and are known to cause bleeding, which especially limits the long-term use of these agents. In addition, not all ACS patients treated with current antiplatelet treatments are protected from recurrence of arterial thrombosis, since many platelet mechanisms and ac...Continue Reading

References

Aug 19, 1991·FEBS Letters·U B RasmussenE Van Obberghen-Schilling
Mar 10, 1998·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·N LiP Hjemdahl
Jun 17, 1998·Proceedings of the National Academy of Sciences of the United States of America·W F XuD C Foster
Mar 18, 1999·Journal of Leukocyte Biology·A R BurnsC W Smith
Mar 23, 1999·British Journal of Haematology·D W Essex, M Li
Sep 28, 1999·The Journal of Experimental Medicine·G M RomoJ A López
Jun 6, 2000·The Journal of Biological Chemistry·M J ShapiroS R Coughlin
Aug 25, 2001·The New England Journal of Medicine·S YusufUNKNOWN Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
Oct 17, 2001·Circulation·W H SauerS E Kimmel
Jan 5, 2002·Proceedings of the National Academy of Sciences of the United States of America·Brian SavageZaverio M Ruggeri
May 8, 2002·Circulation·Jaydeep SarmaIan Dransfield
Nov 2, 2002·Nature Medicine·Zaverio M Ruggeri
Dec 6, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Steffen MassbergMeinrad Gawaz
Apr 3, 2004·Trends in Molecular Medicine·Bruce Furie, Barbara C Furie
Jul 3, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Christelle LecutJohan W M Heemskerk
Apr 19, 2005·Nature Medicine·Shaun P JacksonHatem H Salem
Oct 26, 2005·Circulation·John S DouglasUNKNOWN Cilostazol for Restenosis Trial (CREST) Investigators
Jul 14, 2006·The Journal of Biological Chemistry·Michael HolinstatHeidi E Hamm
Dec 6, 2006·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·S M SaidR Prondzinsky
Sep 11, 2007·Journal of the American College of Cardiology·Anna SeverinoAlfonso Baldi
Apr 18, 2009·Anesthesia and Analgesia·Mark C WesleyJames A Dinardo
Aug 25, 2009·The Journal of Biological Chemistry·Soochong KimSatya P Kunapuli
Nov 20, 2009·Journal of Thrombosis and Haemostasis : JTH·K PrzyklenkA D Michelson
Jan 7, 2010·JAMA : the Journal of the American Medical Association·Janet M TorpyRichard M Glass

❮ Previous
Next ❯

Citations

Aug 18, 2020·Expert Opinion on Drug Safety·Steven G Chrysant, George S Chrysant
Dec 4, 2020·Platelets·Mark R Thomas, Phillip L R Nicolson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved